Bleeding risk assessment in immune thrombocytopenia

Area of Science:

• Hematology
• Clinical Diagnostics

Background:

• Immune thrombocytopenia (ITP) presents bleeding risks due to low platelet counts and impaired platelet function.
• Current platelet function assays (PFAs) are often unreliable in ITP due to low platelet counts (<100,000/μL).

Purpose of the Study:

• To evaluate the Sonoclot analyzer for assessing platelet function in adult acute ITP patients.
• To correlate Sonoclot-derived platelet function with bleeding risk in ITP.

Main Methods:

• Prospective study of 80 newly diagnosed acute ITP patients (<20,000/μL platelets).
• Patients categorized into ITP bleeder (WHO bleeding grade ≥2) and ITP non-bleeder (WHO bleeding grade ≤1) groups.
• Platelet function assessed using the Sonoclot analyzer, unaffected by platelet count.

Main Results:

• Sonoclot analysis revealed significantly lower mean platelet function in the ITP bleeder group (0.2 ± 0.17) compared to the ITP non-bleeder group (1.2 ± 0.52) (p=0.01).
• Lower platelet function on Sonoclot correlated with increased bleeding episodes during a 6-month follow-up in the ITP non-bleeder group.
• Abnormalities in platelet function detected by Sonoclot were more pronounced in ITP patients with a bleeding phenotype.

Conclusions:

• The Sonoclot analyzer is a valuable tool for assessing platelet function in acute ITP, even with severe thrombocytopenia.
• Sonoclot assessment of platelet function can help differentiate bleeding risk in ITP patients.
• Findings may guide therapeutic decisions for acute ITP management.